Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and ...
The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...
Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects ...
GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.
Pfizer Inc. (NYSE: PFE) today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the ...
According to other readers who have Medicare plus private insurance, the cost could be $700 to $800 for five days of medicine. That is out of reach for many people. Pfizer has had sales of over $25 ...
BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product ...
In February of last year, Icon said it would “vigorously” defend a US lawsuit that stated company insiders had “motive and ...
Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. | Astellas is aiding Vir ...
MiBolsilloColombia on MSN
Trump's New Website Is Slashing Drug PricesBut There's a Major Catch You Must Know
The new TrumpRx platform promises huge discounts on prescription drugs. Learn how it works, who can use it, and how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results